Physician profile
Benjamin Robert Keyser
NPI 1194141200
$7,650.07
in general payments reported to CMS, 2019-2025
5 companies · $759 in 2025
The $759 reported for 2025 was more than what 83% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.50 · 2021: $354 · 2022: $454 · 2023: $2,548 · 2024: $3,497 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,316 · Food and Beverage: $2,920 · Consulting Fee: $500 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,316.38 |
| Food and Beverage | $2,920.35 |
| Consulting Fee | $500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $3,108.20 | 2024-2025 | Biohorizons, Biohorizons Dental Implants |
| Zimvie INC. | $2,843.78 | 2023-2025 | |
| Straumann USA LLC | $1,339.82 | 2020-2025 | |
| Stryker Corporation | $311.34 | 2021-2022 | |
| Nobel Biocare USA | $46.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Keyser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.